The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $131,685 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETED AUDITORY PLASTICITY TRAINING TO IMPROVE CENTRAL HEARING IN MILD TBI", will support research to develop innovative approaches for improving central hearing in individuals with mild traumatic brain injury. The grant has a performance...
This $8,000,000 Congressionally Directed Spending for Construction Projects grant was awarded by the U.S. Department of Health and Human Services (CFDA 93.493 - Congressional Directives) to Texas Tech University Health Sciences Center (TTUHSC) on September 30, 2023. The grant will support the construction and renovation of healthcare facilities, as well as the purchase of necessary equipment. As a state-controlled institution of higher learning, TTUHSC will leverage its expertise in biomedical...
The University of Texas Southwestern Medical Center in Dallas, TX has been awarded a $3,000,000 Project Grant under the Congressional Directives program (CFDA 93.493) by the U.S. Department of Health and Human Services. The award, effective September 30, 2023, will fund the construction and renovation of healthcare facilities in the Dallas area over a 3-year period ending on September 29, 2026. The University of Texas System, of which UT Southwestern is a component, has extensive experience as...
The University of Texas Health Science Center of San Antonio (UTHSCSA) received a $978,159 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into purinergic receptor antagonist therapeutics for treating metastatic renal cancer from July 1, 2023 through June 30, 2026. As the prime awardee, UTHSCSA will conduct research to develop medical solutions for cancer on the battlefield and...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
The federal Project Grant award of $433,126 was granted by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The University of Texas Health Science Center at San Antonio (UTHSCSA). The funding will support a 3-year research project, from January 1, 2025 to December 31, 2027, focused on "Exploring the Role of PACAP38 in Post-Traumatic Headache". UTHSCSA, a prominent academic medical center with expertise in biomedical research and...
The University of New Mexico Health Sciences Center (UNM HSC) has been awarded a $12,000,000 Project Grant under the Congressional Directives program (CFDA 93.493) by the Department of Health and Human Services. This award will fund the construction and renovation of healthcare facilities in New Mexico over a 3-year period from September 30, 2023 to September 29, 2026. The Congressional Directives program supports a range of community-based healthcare, mental health, and social service...
This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative scientific...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...